| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,058,700 | 1,079,062 | 1,093,375 | 1,105,434 | | Cost of Revenue | 672,053 | 684,549 | 711,040 | 732,239 | | | Gross Profit | 386,647 | 394,513 | 382,335 | 373,195 | | | Operating Expenses | | Research Development | 10 | 254 | 1,285 | 1,153 | | Selling General and Administrative | 195,984 | 152,656 | 159,271 | 162,019 | | Non Recurring | 176,648 | 66,075 | 95,020 | 40,730 | | Others | 185,350 | 139,249 | 161,138 | 141,098 | | | | Total Operating Expenses | 557,992 | 358,234 | 416,714 | 345,000 | | | | Operating Income or Loss | (171,345) | 36,279 | (34,379) | 28,195 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,465 | (194) | 10,722 | 10,424 | | Earnings Before Interest And Taxes | (167,880) | 36,085 | (23,657) | 38,619 | | Interest Expense | 64,871 | 71,118 | 128,116 | 90,535 | | Income Before Tax | (232,751) | (35,033) | (151,773) | (51,916) | | Income Tax Expense | (54,488) | 813 | (40,167) | (19,425) | | Minority Interest | (1,240) | 1,240 | 286 | 283 | | | | Net Income From Continuing Ops | (179,503) | (34,606) | (111,320) | (32,208) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (179,503) | (34,606) | (111,320) | (32,208) | | Preferred Stock And Other Adjustments | (35,961) | (53,074) | (25,206) |
-
| | | Net Income Applicable To Common Shares | ($215,464) | ($87,680) | ($136,526) | ($32,208) |
|
0.63% Nasdaq 
0.03%
Income Statement
